Antoine Papiernik is a Managing Partner at the life sciences VC firm Sofinnova Partners. He has been an initial investor and active board member in Actelion, ProQR, NovusPharma, Movetis, Mainstay, Pixium Vision and Stentys, among others.

Articles by Antoine Papiernik

Opinion 14 Mar 2022

The Secrets to 50 Years of Success in Life Sciences Investment

Opinion 7 Jul 2021

Three Lessons an Investor Can Learn from Biotech Entrepreneurs

Opinion 16 Jul 2019

The Business of Biotech: What to Do When the S*#t Hits the Fan